These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 21152784)

  • 1. Association of emblica, licorice and belides as an alternative to hydroquinone in the clinical treatment of melasma.
    Costa A; Moisés TA; Cordero T; Alves CR; Marmirori J
    An Bras Dermatol; 2010; 85(5):613-20. PubMed ID: 21152784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, double-blind, placebo-controlled clinical trial on the efficacy and safety of 3% Rumex occidentalis cream versus 4% hydroquinone cream in the treatment of melasma among Filipinos.
    Mendoza CG; Singzon IA; Handog EB
    Int J Dermatol; 2014 Nov; 53(11):1412-6. PubMed ID: 25265986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of 4% hydroquinone combined with 10% glycolic acid, antioxidants, and sunscreen in the treatment of melasma.
    Guevara IL; Pandya AG
    Int J Dermatol; 2003 Dec; 42(12):966-72. PubMed ID: 14636195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treating epidermal melasma with a 4% hydroquinone skin care system plus tretinoin cream 0.025%.
    Grimes P; Watson J
    Cutis; 2013 Jan; 91(1):47-54. PubMed ID: 23461059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinical, prospective, randomized, double-blind trial comparing skin whitening complex with hydroquinone vs. placebo in the treatment of melasma.
    Haddad AL; Matos LF; Brunstein F; Ferreira LM; Silva A; Costa D
    Int J Dermatol; 2003 Feb; 42(2):153-6. PubMed ID: 12709008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the efficacy and safety of combinations of hydroquinone, glycolic acid, and hyaluronic acid in the treatment of melasma.
    Ibrahim ZA; Gheida SF; El Maghraby GM; Farag ZE
    J Cosmet Dermatol; 2015 Jun; 14(2):113-23. PubMed ID: 25847063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of therapeutic effects of 20% azelaic acid and hydroquinone 4% cream in the treatment of melasma.
    Farshi S
    J Cosmet Dermatol; 2011 Dec; 10(4):282-7. PubMed ID: 22151936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect of Topical Use of Petroselinum Crispum (Parsley) Versus That of Hydroquinone Cream on Reduction of Epidermal Melasma: A Randomized Clinical Trial.
    Khosravan S; Alami A; Mohammadzadeh-Moghadam H; Ramezani V
    Holist Nurs Pract; 2017; 31(1):16-20. PubMed ID: 27902522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a kojic acid, emblica extract, and glycolic acid formulation compared with hydroquinone 4% for skin lightening.
    Draelos ZD; Yatskayer M; Bhushan P; Pillai S; Oresajo C
    Cutis; 2010 Sep; 86(3):153-8. PubMed ID: 21049734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The first clinical experience on efficacy of topical flutamide on melasma compared with topical hydroquinone: a randomized clinical trial.
    Adalatkhah H; Sadeghi-Bazargani H
    Drug Des Devel Ther; 2015; 9():4219-25. PubMed ID: 26345129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of therapeutic effects of liposomal Tranexamic Acid and conventional Hydroquinone on melasma.
    Banihashemi M; Zabolinejad N; Jaafari MR; Salehi M; Jabari A
    J Cosmet Dermatol; 2015 Sep; 14(3):174-7. PubMed ID: 26177992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of hydroquinone-resistant melasma using topical methimazole.
    Malek J; Chedraoui A; Nikolic D; Barouti N; Ghosn S; Abbas O
    Dermatol Ther; 2013; 26(1):69-72. PubMed ID: 23384022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An efficacy study of 3 commercially available hydroquinone 4% treatments for melasma.
    Grimes PE
    Cutis; 2007 Dec; 80(6):497-502. PubMed ID: 18246882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of topical isobutylamido thiazolyl resorcinol (Thiamidol) vs. 4% hydroquinone cream for facial melasma: an evaluator-blinded, randomized controlled trial.
    Lima PB; Dias JAF; Cassiano DP; Esposito ACC; Miot LDB; Bagatin E; Miot HA
    J Eur Acad Dermatol Venereol; 2021 Sep; 35(9):1881-1887. PubMed ID: 33988887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Evaluation of Efficacy and Tolerability of Glycolic Acid, Salicylic Mandelic Acid, and Phytic Acid Combination Peels in Melasma.
    Sarkar R; Garg V; Bansal S; Sethi S; Gupta C
    Dermatol Surg; 2016 Mar; 42(3):384-91. PubMed ID: 26859648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical silymarin versus hydroquinone in the treatment of melasma: A comparative study.
    Nofal A; Ibrahim AM; Nofal E; Gamal N; Osman S
    J Cosmet Dermatol; 2019 Feb; 18(1):263-270. PubMed ID: 30146802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the efficacy of cysteamine cream compared to hydroquinone in the treatment of melasma: A randomised, double-blinded trial.
    Nguyen J; Remyn L; Chung IY; Honigman A; Gourani-Tehrani S; Wutami I; Wong C; Paul E; Rodrigues M
    Australas J Dermatol; 2021 Feb; 62(1):e41-e46. PubMed ID: 32981068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigator-Blinded, Single-Center Study to Evaluate the Efficacy and Tolerability of a 4% Hydroquinone Skin Care System Plus 0.02% Tretinoin Cream in Mild-to-Moderate Melasma and Photodamage.
    Rendon M; Dryer L
    J Drugs Dermatol; 2016 Apr; 15(4):466-75. PubMed ID: 27050702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind randomized trial of 5% ascorbic acid vs. 4% hydroquinone in melasma.
    Espinal-Perez LE; Moncada B; Castanedo-Cazares JP
    Int J Dermatol; 2004 Aug; 43(8):604-7. PubMed ID: 15304189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of hydroquinone by Raman spectroscopy in patients with melasma before and after treatment.
    Cabrera-Alonso R; Guevara E; Ramírez-Elías MG; Moncada B; González FJ
    Skin Res Technol; 2019 Jan; 25(1):20-24. PubMed ID: 29790609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.